Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
946.00    6.00 (0.64%)
Bid:
940.00
Ask:
952.00
Spread: 12.00 (1.277%)
Market Cap: £258.93m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full-Year Trading Update

4 Oct 2011 07:00

RNS Number : 4702P
Gooch & Housego PLC
04 October 2011
 



 

For immediate release

4 October 2011

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Full-Year Trading Update

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, today announces that results for the year ended 30 September 2011will be in line with market expectations. Preliminary results will be announced on 29 November 2011.

 

Favourable market conditions prevailed for the first three quarters of the year and strong demand was experienced across most market and product sectors. The acquisitions of EM4 and Crystal Technology during the second quarter contributed to revenue and profit growth and accelerated the diversification of the business. G&H's presence in the aerospace & defence, life sciences and telecommunications markets has been significantly enhanced, while the Company's market leadership in acousto-optics and electro-optics for industrial applications has also been reinforced. Given the fragile global economic environment we did anticipate some softening in demand in the final quarter, although this has been confined to certain product sectors and geographical markets. Greater diversification and growth in new markets has mitigated some of the effects of the slowing demand in other sectors.

 

The integration of the new acquisitions is progressing well. The rationale for G&H's acquisition of EM4 was demonstrated by a number of significant contract wins for strategic defence programs including the recent award of a $3+ million contract by a large US defence contractor for the first phase of the design, development and supply of fibre optic systems. Plans to duplicate G&H Torquay's passive fibre optics technology at EM4's Boston site, in order to access the large US aerospace & defence market for these products, are already well-advanced with the first products expected to be available for qualification testing in early 2012.

 

Crystal Technology has performed strongly during the first six months of G&H ownership, with revenues from all major markets exceeding original plan. The transfer of crystal growing from the Crystal Technology facility in Palo Alto to G&H's Cleveland operation - a major undertaking requiring the fitting out of a new 30,000 square foot facility - is making good progress. The facility is essentially complete and the first crystals have been grown. It is expected that production will be fully transferred by the end of the calendar year.

 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

 

"During the past twelve months we have made progress towards achieving the key strategic and commercial objectives of greater diversification and strong organic and acquisitive growth. The uncertain economic climate will present challenges in the coming year but Gooch & Housego is well-positioned to deliver the next phase of its strategy as we seek to leverage the exceptional products, technologies and capabilities that the company now has to offer."

 

For further information please contact:

 

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Nicola Cronk, Buchanan, 020 7466 5000

Patrick Robb/James Grace, Investec Bank plc, 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSDFMDFFSEDS
Date   Source Headline
9th Mar 20097:00 amRNSMarket Update
29th Jan 20094:04 pmRNSTrading Update
1st Dec 200810:56 amRNSDirector Share Dealing
25th Nov 200812:27 pmRNSPreliminary Results - Replacement
25th Nov 20087:00 amRNSPreliminary Results
5th Nov 20087:00 amRNSNotice of Results
10th Oct 20087:00 amRNSAcquisition of General Optics
9th Oct 20087:00 amRNSFull Year Trading Update
25th Sep 200811:47 amRNSInvestor and Analyst Site Visits
19th Sep 20083:11 pmRNSShare Option Purchase
4th Jul 20087:00 amRNSAcquisition of General Optics
24th Jun 20087:00 amRNSChange of NOMAD & Broker
17th Jun 20087:00 amRNSInterim Results
27th May 20087:00 amRNSIFRS
13th May 20086:00 amRNSNotice of Results
9th Apr 20087:00 amRNSTrading Update
28th Mar 20089:59 amRNSAnnual Report and Accounts
12th Mar 20084:37 pmRNSAdditional Listing
13th Feb 200811:00 amRNSAGM Statement
5th Feb 20087:01 amRNSVendor Appreciation Award
22nd Jan 20087:01 amRNSGlobal Integration
7th Jan 20088:53 amRNSAdditional Listing
7th Jan 20087:01 amRNSSIFAM Order
4th Jan 200812:32 pmRNSDirector Shareholding
21st Dec 20074:46 pmRNSHolding(s) in Company
21st Dec 20074:35 pmRNSAdditional Listing
7th Dec 20073:00 pmRNSLong Term Incentive Plan
3rd Dec 200712:20 pmRNSAdditional Listing
30th Nov 20073:44 pmRNSHolding(s) in Company
27th Nov 20077:00 amRNSAppointment
27th Nov 20077:00 amRNSPreliminary Results
15th Nov 20077:01 amRNSAppointment
29th Oct 20077:01 amRNSNotice of Results
4th Oct 20077:01 amRNSFull Year Trading Update
23rd Aug 20078:26 amRNSAdditional Listing
22nd Aug 20075:38 pmRNSDirector Shareholdings
17th Aug 20076:23 pmRNSAIM Rule 26
16th Aug 20072:12 pmRNSAdditional Listing
14th Aug 200712:36 pmRNSLTIP Awards
10th Aug 20075:18 pmRNSDirector Shareholdings
17th Jul 20074:16 pmRNSDirector of Sales Appointment
5th Jun 20077:02 amRNSInterim Results
31st May 20079:55 amRNSTotal Voting Rights
10th May 20079:58 amRNSHolding(s) in Company
9th May 20077:01 amRNSNotice of Results
8th May 20071:53 pmRNSAdditional Listing
8th May 20077:02 amRNSAcquisition
11th Apr 20077:01 amRNSTrading Update
8th Mar 20075:54 pmRNSHolding(s) in Company
14th Feb 20077:01 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.